Jianchun Duan
9PUBLICATIONS
64CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.Jian-Chun Duan, Jia Zhong, Bo-Yang Sun
|Feb 24, 2025
Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.Jiefei Han, Yiting Dong, Xiuli Zhu
|Feb 08, 2024
Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy.Jiefei Han, Yiting Dong, Xiuli Zhu
|Oct 14, 2023
Biomarkers for Immunotherapy in Driver-Gene-Negative Advanced NSCLC.Yiyi Huang, Yi-Fung Chau, Hua Bai
|Apr 07, 2023
Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors.Boyang Sun, Tian Qiu, Xiaoling Zeng
|Nov 26, 2022
Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer.Yiting Dong, Yixiang Zhu, Minglei Zhuo
Pageof 2
